D. All of the above
c. sickle cell anemia
D. All of the above
C. amplifies low levels of specific DNA sequences
D. all of the above
D. Both A and B
A. Sanger method
D. all of the above
D. It is useful in the diagnosis of various anemias.
*10. Microarrays are
A. DNA probes bonded on glass chips
B. tissue-based probes
C. used to identify single-base mutations
D. used to determine clonality in lymphomas
A. DNA probes bonded on glass chips
*11. Molecular techniques provide a diagnostic tool to
A. detect MRD in hematological malignancies
B. monitor patients following bone marrow transplantation
C. detect an early relapse in a patient treated for a hematological malignancy
D. all of the above
D. all of the above
*12. Which of the following best describes the molecular alteration of the Philadelphia chromosome to chronic myelogenous leukemia (CML)?
A. The mutation produces an overly active tyrosine kinase that increases apoptosis.
B. The mutation reduces serine enzyme activity in affected cells.
C. The mutation involves translocation of a gene that is critical to myelocytic maturation.
D. Hematopoietic cells gain a proliferation advantage because of tyrosine kinase activity.
C. The mutation involves translocation of a gene that is critical to myelocytic maturation.
*12. Which of the following best describes the molecular alteration of the Philadelphia chromosome to chronic myelogenous leukemia (CML)?
A. The mutation produces an overly active tyrosine kinase that increases apoptosis.
B. The mutation reduces serine enzyme activity in affected cells.
C. The mutation involves translocation of a gene that is critical to myelocytic maturation.
D. Hematopoietic cells gain a proliferation advantage because of tyrosine kinase activity.
C. The mutation involves translocation of a gene that is critical to myelocytic maturation.